Black Diamond Therapeutics(BDTX.US)

Last Updated 19:00:00 ET
longbridge loading

MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On Watch

rttnews·
US
ADIL
+0.87%
US
BDTX
+20.70%
US
EDSA
-6.11%
rttnews·
US
ADIL
+0.87%
US
BDTX
+20.70%
US
EDSA
-6.11%

Analyst Reiterates Buy on Black Diamond Therapeutics, Citing Differentiated EGFR Inhibitor and Strong Cash Runway Through 2028

Tip Ranks·
US
BDTX
+20.70%
US
IBB
+1.74%
US
PBE
+0.89%
Tip Ranks·
US
BDTX
+20.70%
US
IBB
+1.74%
US
PBE
+0.89%

Black Diamond Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
BDTX
+20.70%
Earnings Watch·
US
BDTX
+20.70%

Black Diamond Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
BDTX
+20.70%
Earnings Watch·
US
BDTX
+20.70%

Black Diamond Group declares CAD 0.045 dividend

MSN·
US
BDTX
+20.70%
MSN·
US
BDTX
+20.70%

Black Diamond Therapeutics | 10-K: FY2025 Revenue: USD 70 M

Earnings Watch·
US
BDTX
+20.70%
Earnings Watch·
US
BDTX
+20.70%

Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting | BDTX Stock News

StockTitan·
US
BDTX
+20.70%
US
FBT
+1.45%
US
LABU
+10.08%
StockTitan·
US
BDTX
+20.70%
US
FBT
+1.45%
US
LABU
+10.08%

Black Diamond Sets Date for Q1 2026 Results and Investor Call

Tip Ranks·
US
FBT
+1.45%
US
BIB
+3.26%
US
BDTX
+20.70%
Tip Ranks·
US
FBT
+1.45%
US
BIB
+3.26%
US
BDTX
+20.70%
© 2026 Longbridge｜Disclaimer